Holger Weis - Net Worth and Insider Trading

Holger Weis Net Worth

The estimated net worth of Holger Weis is at least $2,267 dollars as of 2024-11-13. Holger Weis is the Director of Alaunos Therapeutics Inc and owns about 929 shares of Alaunos Therapeutics Inc (TCRT) stock worth over $2,267. Details can be seen in Holger Weis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Holger Weis has not made any transactions after 2021-09-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Holger Weis

To

Holger Weis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Holger Weis owns 1 companies in total, including Alaunos Therapeutics Inc (TCRT) .

Click here to see the complete history of Holger Weis’s form 4 insider trades.

Insider Ownership Summary of Holger Weis

Ticker Comapny Transaction Date Type of Owner
TCRT Alaunos Therapeutics Inc 2022-06-22 director

Holger Weis Latest Holdings Summary

Holger Weis currently owns a total of 1 stock. Holger Weis owns 929 shares of Alaunos Therapeutics Inc (TCRT) as of September 1, 2021, with a value of $2,267.

Latest Holdings of Holger Weis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TCRT Alaunos Therapeutics Inc 2021-09-01 929 2.44 2,267

Holding Weightings of Holger Weis


Holger Weis Form 4 Trading Tracker

According to the SEC Form 4 filings, Holger Weis has made a total of 1 transactions in Alaunos Therapeutics Inc (TCRT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Alaunos Therapeutics Inc is the acquisition of 333 shares on September 1, 2021, which cost Holger Weis around $91,500.

Insider Trading History of Holger Weis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Holger Weis Trading Performance

GuruFocus tracks the stock performance after each of Holger Weis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Holger Weis is -29.05%. GuruFocus also compares Holger Weis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Holger Weis within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Holger Weis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Holger Weis

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.79 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.48 LIMIT LIMIT LIMIT LIMIT LIMIT

Holger Weis Ownership Network

Ownership Network List of Holger Weis

No Data

Ownership Network Relation of Holger Weis

Insider Network Chart

Holger Weis Owned Company Details

What does Alaunos Therapeutics Inc do?

Who are the key executives at Alaunos Therapeutics Inc?

Holger Weis is the director of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .

Alaunos Therapeutics Inc (TCRT) Insider Trades Summary

Over the past 18 months, Holger Weis made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,

In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453 shares.

Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alaunos Therapeutics Inc Insider Transactions

No Available Data

Holger Weis Mailing Address

Above is the net worth, insider trading, and ownership report for Holger Weis. You might contact Holger Weis via mailing address: C/o Ziopharm Oncology, Inc., One First Avenue, Parris Bldg 34, Boston Ma 02129.